Multicenter randomized crossover trial evaluating the provox luna in laryngectomized subjects

Autor: Chathura B B Ratnayake, Michiel W. M. van den Brekel, Pauline H.E. Janssen‐van Det, Rob van Son, I. Bing Tan, Laura W. J. Baijens, Walmari Pilz, Cees A. Meeuwis, Renske Fles
Přispěvatelé: KNO, MUMC+: MA Keel Neus Oorheelkunde (9), RS: GROW - R2 - Basic and Translational Cancer Biology, Promovendi MHN, Otorhinolaryngology and Head and Neck Surgery, Maxillofacial Surgery (AMC)
Rok vydání: 2018
Předmět:
Male
medicine.medical_treatment
Laryngology
TRACHEAL CLIMATE
0302 clinical medicine
Tracheostomy
skin irritation
University medical
Airway Management
030223 otorhinolaryngology
TEMPERATURE
Netherlands
Aged
80 and over
tracheostoma
Cross-Over Studies
HME compliance
total laryngectomy
Middle Aged
Laryngectomy
Skin irritation
Treatment Outcome
030220 oncology & carcinogenesis
Provox Luna
Female
POSTLARYNGECTOMY PULMONARY
HUMIDITY
PULMONARY REHABILITATION
medicine.medical_specialty
HEAT
Prosthesis Design
MUCOCILIARY CLEARANCE
03 medical and health sciences
HME
SDG 3 - Good Health and Well-being
Original Reports
medicine
Humans
Aged
business.industry
Crossover study
Heat and moisture exchanger
MOISTURE EXCHANGER USE
Otorhinolaryngology
Usual care
Physical therapy
Patient Compliance
adhesives
business
Larynx
Artificial
Zdroj: The Laryngoscope
Ratnayake, C B B, Fles, R, Tan, I B, Baijens, L W J, Pilz, W, Meeuwis, C A, Janssen-van Det, P H E, van Son, R & Van den Brekel, M W M 2019, ' Multicenter randomized crossover trial evaluating the provox luna in laryngectomized subjects ', The Laryngoscope, vol. 129, no. 10, pp. 2354-2360 . https://doi.org/10.1002/lary.27839
Laryngoscope, 129(10), 2354-2360. Wiley
Laryngoscope, 129(10), 2354-2360. Wiley-Blackwell
The Laryngoscope, 129(10), 2354-2360. John Wiley and Sons Inc.
ISSN: 1531-4995
0023-852X
DOI: 10.1002/lary.27839
Popis: Objectives: The aim of this study was to compare the relative compliance and the dermatological and pulmonary outcomes when the Provox Luna system (Atos Medical, Malmö, Sweden) is added during the night to the usual tracheastoma care of laryngectomized subjects. Methods: This was a multicenter randomized crossover trial conducted in the Netherlands Cancer Institute, Erasmus Medical Center, and Maastricht University Medical Center in The Netherlands. The study included 46 laryngectomized subjects with prior heat and moisture exchanger (HME) and adhesive experience. Results: A significant improvement in the number of compliant individuals was found: Luna: n = 43 of 45 (96%); usual care: n = 35 of 46 (76%), P = 0.02. The Luna period was associated with longer intervals of daily HME use (Luna 23.2 hours [range: 15.6–24.0 hours], usual care [UC]: 21.5 hours [range: 6.0–24.0 hours], P = 0.003) and an increased frequency of skin improvement overnight (Luna 3.9 days [standard deviation (SD)]: 7.0 days), Usual Care: 8.1 days ([SD: 10.8 days], P = 0.008). Fifty-six percent (n = 26) of participants wanted to continue using the Provox Luna system at the conclusion of the study. Conclusion: An improvement in compliance and skin recovery overnight was observed when the Provox Luna was added to the usual adhesive and HME use. Therefore, there is utility in supplementing the usual post-total laryngectomy care with the Provox Luna system at night, particularly in the setting of compliance concerns and in subjects who desire dermatological relief overnight. Level of Evidence: 1b. Laryngoscope, 129:2354–2360, 2019.
Databáze: OpenAIRE
Externí odkaz: